Literature DB >> 32888640

Systematizing Heart Failure Population Health.

Prateeti Khazanie1, Larry A Allen2.   

Abstract

Population health and population health management of patients with heart failure aim to identify all patients with the condition in a population, to characterize and risk stratify subgroups of patients, to improve care delivery by leveraging technology and data so providers can improve care coordination, to engage disease management programs, and to create cost-effective health systems that reduce financial burden on patients and providers. This requires a shift in our treatment paradigm from reactive treatment to proactive primary and secondary prevention. Shifts from fee-for-service to value-based payment models promise to encourage population health.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health policy; Heart failure; Population health; Population medicine; Process improvement; Value

Mesh:

Year:  2020        PMID: 32888640      PMCID: PMC7737815          DOI: 10.1016/j.hfc.2020.06.006

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  48 in total

1.  Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.

Authors:  Adam D DeVore; Bradley G Hammill; N Chantelle Hardy; Zubin J Eapen; Eric D Peterson; Adrian F Hernandez
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

Review 2.  Polypharmacy in heart failure: drugs to use and avoid.

Authors:  Brent N Reed; Jo E Rodgers; Carla A Sueta
Journal:  Heart Fail Clin       Date:  2014-08-13       Impact factor: 3.179

3.  Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF.

Authors:  Muthiah Vaduganathan; Brian L Claggett; Akshay S Desai; Stefan D Anker; Sergio V Perrone; Stefan Janssens; Davor Milicic; Juan L Arango; Milton Packer; Victor C Shi; Martin P Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2019-11-11       Impact factor: 24.094

Review 4.  Patient selection for left ventricular assist devices.

Authors:  Prateeti Khazanie; Joseph G Rogers
Journal:  Congest Heart Fail       Date:  2011-07-21

5.  Patient selection for advanced heart failure therapy referral.

Authors:  Alexander C Fanaroff; Adam D DeVore; Robert J Mentz; Mani A Daneshmand; Chetan B Patel
Journal:  Crit Pathw Cardiol       Date:  2014-03

6.  Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry.

Authors:  Haider J Warraich; Haolin Xu; Adam D DeVore; Roland Matsouaka; Paul A Heidenreich; Deepak L Bhatt; Adrian F Hernandez; Clyde W Yancy; Gregg C Fonarow; Larry A Allen
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

7.  Multi-Center, Community-Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes.

Authors:  Nigel Gupta; Mary Lou Kiley; Faith Anthony; Charlie Young; Somjot Brar; Kevin Kwaku
Journal:  J Am Heart Assoc       Date:  2016-03-09       Impact factor: 5.501

8.  Does Race Influence Decision Making for Advanced Heart Failure Therapies?

Authors:  Khadijah Breathett; Erika Yee; Natalie Pool; Megan Hebdon; Janice D Crist; Shannon Knapp; Ashley Larsen; Sade Solola; Luis Luy; Kathryn Herrera-Theut; Leanne Zabala; Jeff Stone; Marylyn M McEwen; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  J Am Heart Assoc       Date:  2019-11-11       Impact factor: 5.501

Review 9.  The Rise of Consumer Health Wearables: Promises and Barriers.

Authors:  Lukasz Piwek; David A Ellis; Sally Andrews; Adam Joinson
Journal:  PLoS Med       Date:  2016-02-02       Impact factor: 11.069

10.  Discussing Out-of-Pocket Costs With Patients: Shared Decision Making for Sacubitril-Valsartan in Heart Failure.

Authors:  Graham H Smith; Supriya Shore; Larry A Allen; David W Markham; Andrea R Mitchell; Miranda Moore; Alanna A Morris; Candace D Speight; Neal W Dickert
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.